Study Probes Corticosteroid Dependence in Polymyalgia Rheumatica

Background/Purpose Polymyalgia rheumatica (PMR) treatment is primarily based on long-term corticosteroids, which results in significant toxicities. Studies have shown that patients with PMR are exposed to years of corticosteroid treatment.1,2 In a single academic center cohort, we found that 76% of patients remained on steroids at the end of two years.3 In a second cohort...

Source: The Rheumatologist - January 24, 2024 Category: Rheumatology Authors: Vivekanand Tiwari, MD, Emily Campbell, MD, Joshua Skydel, MD, Bryan Savage, MD, Monica Dimambro, Todd MacKenzie, PhD, & William F. Rigby, MD Tags: Biologics/DMARDs Conditions Drug Updates Other Rheumatic Conditions Research Rheum Corticosteroids Glucocorticoids PMR FocusRheum Polymyalgia Rheumatica Research Review Source Type: research